Table 2 Summary of treatment-emergent AEs in safety-assessment patient population

From: A multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability